Brookline Capital Markets analyst Kemp Dolliver assumed coverage of Bioceres Crop Solutions (NASDAQ:BIOX) with a “buy” rating and $18 price target. The stock closed at $14.90 on May 7. Bioceres is the market leader in...
Brookline Capital Markets initiated coverage of BioCeres Crop Solutions (NASDAQ:BIOX) with a “buy” rating and $13 price target. The stock closed at $4.95 on Feb. 4. BioCeres is the market leader in South America...